ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 7c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• United Community Banks completes $2B Navitas sale to Wafra
• NVIDIA (NVDA) Said To Near $14 bln Deal For Hugging Face This Week - Bloomberg